Form 4: Prestige Consumer Healthcare CFO Exercises and Sells Shares

Prestige Consumer Healthcare's Chief Financial Officer, Christine Sacco, exercised stock options and sold shares on November 12, 2024.

Summary

• Christine Sacco, the Chief Financial Officer of Prestige Consumer Healthcare, engaged in transactions involving the company's stock on November 12, 2024.
• She exercised 24,686 employee stock options at a price of $30.56 per share.
• Following the exercise, she sold 24,686 shares at a weighted average price of $82.01 per share.
• The sale was executed through multiple open market transactions with prices ranging from $81.87 to $82.30.
• After these transactions, Ms. Sacco beneficially owns 30,123 shares of Prestige Consumer Healthcare.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing an insider transaction. It does not convey any positive or negative sentiment about the company's performance or outlook.

Industry Context

This is a routine filing related to insider transactions and is common for executives who hold stock options in publicly traded companies. It does not indicate any specific trend in the consumer healthcare industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical executive compensation and trading activities.
• Similar filings are regularly made by executives at companies like Church & Dwight (CHD) and Johnson & Johnson (JNJ) when they exercise options or sell shares.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves a relatively small number of shares compared to the total outstanding shares.
• The sale of shares by the CFO could be perceived as a slight negative signal by some investors, but it is a common practice for executives to diversify their holdings.

Key Dates

Keywords

Prestige Consumer Healthcare, stock options, insider trading, Form 4, share sale, Christine Sacco, CFO